NEXAVAR IN TREATMENT OF HEPATOCELLULAR CARCINOMA

NEXAVAR IN TREATMENT OF HEPATOCELLULAR CARCINOMA

Hepatocellular carcinoma (HCC) is a significant health problem. Globally is the second most common cause of cancer-associated death and the fifth most frequent neoplasm. The main risk factors for the onset of HCC are well recognized, including the presence of cirrhosis, chronic hepatitis C and hep...

Full description

Bibliographic Details
Main Authors: Gabriela Smira, Adina Croitoru, Andra Visan, Ioana Luca, Iulia Gramaticu, Florina Buica, Ioana Dinu, Vladislav Brasoveanu, Doina Hrehoret, Irinel Popescu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2018-12-01
Series:Romanian Journal of Medical Practice
Subjects:
sorafenib
hepatocellular carcinoma
cirrhosis
Online Access:https://revistemedicale.amaltea.ro/Romanian_Journal_of_MEDICAL_PRACTICE/Practica_medicala-2018-Nr.4/RJMP_2018_4_Art-07.pdf

Similar Items

Similar Items